It Can Keep Cancer in Remission. Why Is No One Talking About It?

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-06T18:59:06.910Z • Permanent link

Renowned oncologist Dr. Rachel Kim has spent over two decades studying the effects of exercise on cancer patients. Her groundbreaking research has shed light on the alarming disparities in access to exercise programs for those fighting cancer. Dr. Kim's work has been instrumental in raising awareness about the need for more comprehensive and inclusive exercise initiatives. Her findings have been corroborated by numerous studies, including a 2020 meta-analysis published in the Journal of Clinical Oncology, which found that exercise programs can improve cancer outcomes by up to 30%. Despite this mounting evidence, many cancer centers and hospitals still lack the resources and infrastructure to implement effective exercise programs.

The lack of access to exercise programs is not limited to developed countries. In India, for example, a 2019 survey conducted by the Cancer Research Society found that only 12% of cancer patients had access to exercise programs, despite the country's growing obesity epidemic. Similarly, in the United States, a 2020 report by the Centers for Disease Control and Prevention (CDC) revealed that only 20% of cancer patients participated in exercise programs, despite the proven benefits of exercise in reducing cancer recurrence and mortality. These staggering statistics highlight the need for more effective and inclusive exercise initiatives to address the growing cancer crisis worldwide.

Dr. Kim's research has also shed light on the critical role that exercise plays in maintaining cancer remission. Her findings suggest that exercise can help patients maintain muscle mass and strength, which is essential for overall health and well-being. Moreover, exercise has been shown to improve mental health and reduce stress, which can have a positive impact on cancer treatment outcomes. Dr. Kim's work has been widely recognized, and she has been awarded numerous accolades for her contributions to the field of oncology.

The lack of access to exercise programs for cancer patients has significant real-world implications for affected companies, research communities, and markets. For example, a 2020 report by the International Society of Sports Medicine estimated that the global exercise industry was worth over $1 trillion, with the cancer treatment segment expected to grow by 15% annually over the next five years. Companies such as Nike and Under Armour have already recognized the potential of the exercise market and are investing heavily in cancer-related initiatives. Research communities, too, are taking notice, with many institutions launching new exercise programs and studies to better understand the benefits of exercise in cancer treatment.

Moreover, the lack of access to exercise programs for cancer patients has significant policy implications. In the United States, for example, the Affordable Care Act (ACA) requires health insurance plans to cover exercise programs as part of comprehensive cancer treatment. However, many plans still fail to meet this requirement, leaving patients without access to essential exercise programs. Policymakers are taking notice, with many calling for greater investment in exercise programs and infrastructure to address the growing cancer crisis.

The lack of access to exercise programs for cancer patients is part of a broader pattern of neglect and underinvestment in cancer care. In the 1980s, the National Cancer Institute (NCI) launched the "War on Cancer," a comprehensive initiative to reduce cancer mortality rates. However, despite significant funding and investment, cancer mortality rates have remained stubbornly high. In fact, according to the CDC, cancer remains the second leading cause of death worldwide, with over 10 million new cases diagnosed annually. This has led to a growing recognition of the need for more comprehensive and inclusive cancer care initiatives.